首页|曲美他嗪对老年慢性心力衰竭患者心功能、心率变异性的影响

曲美他嗪对老年慢性心力衰竭患者心功能、心率变异性的影响

扫码查看
目的 探究曲美他嗪对老年慢性心力衰竭(心衰)患者心功能、心率变异性的影响.方法 将 2021 年 6 月至2022 年6 月开封市人民医院收治的310 例慢性心衰患者纳入研究,随访脱落6 例,共记304 例,随机分为2 组(曲美他嗪组,常规组),各152 例.常规组采用标准抗心衰治疗方案治疗,曲美他嗪组在常规组的方案上联用曲美他嗪配合治疗,治疗时间为3 个月.比较两组的疗效、心率、六分钟步行距离试验、心功能指标和心率变异性指标;记录药物不良反应发生情况.结果 曲美他嗪组疗效高于常规组(P<0.05);治疗后,两组患者的HR水平差异无统计学意义(P>0.05),六分钟步行距离高于常规组(P<0.05);曲美他嗪组左心室射血分数高于常规组,左心室舒张末期内径、收缩期内径低于常规组(P<0.05);曲美他嗪组RR间期的标准差、RR间期平均标准差水平高于常规组(P<0.05);两组不良反应差异无统计学意义(P>0.05).结论 曲美他嗪能有效改善老年慢性心衰患者的心功能、同时提高患者的心率变异性水平.
Effects of Trimetazidine on Cardiac Function and Heart Rate Variability in Elderly Patients with Chronic Heart Failure
Objective To investigate the effects of trimetazidine on heart function and heart rate variability in elderly patients with chronic heart failure(CHF).Methods A total of 310 patients with chronic heart failure admitted to Kaifeng People's Hospital from June 2021 to June 2022 were included in the study,and 6 patients dropped out during follow-up.A total of 304 patients were re-corded and randomly divided into two groups(trimetazidine group and conventional group),with 152 cases in each group.The con-ventional group received standard anti-heart failure treatment,while the trimetazidine group received combined treatment with trimetaz-idine in the conventional group for a duration of 3 months.The efficacy,heart rate,6-minute walking distance,heart function index and heart rate variability index were compared between the two groups;the occurrence of adverse drug reactions was recorded.Results The therapeutic effect of the combination group was higher than that of the conventional group(P<0.05);after treatment,there was no significant difference in HR levels between the two groups(P>0.05),and the 6-minute walking distance was higher than that of the control group(P<0.05);the left ventricular ejection fraction in the combination group was higher than that in the control group,and the left ventricular end diastolic diameter and systolic diameter were lower than those in the control group(P<0.05);the stand-ard deviation and average standard deviation of RR interval in the combined group were higher than those in the conventional group(P<0.05);there was no significant difference in adverse reactions between the two groups(P>0.05).Conclusion Trimetazidine can improve heart function,and increase heart rate variability levels in elderly patients with chronic heart failure.

elderlychronic heart failurespironolactonetrimetazidine

宋丽丽、赵闯、要静、常伟纳

展开 >

开封市人民医院药剂科,河南 开封 475000

老年 慢性心力衰竭 螺内酯 曲美他嗪

开封市科技发展计划项目

2103048

2024

锦州医科大学学报
辽宁医学院

锦州医科大学学报

影响因子:0.802
ISSN:1674-0424
年,卷(期):2024.45(4)